The Ginetta G55 GT3 will return to British GT grid in 2017 complete with an upgraded specification and a brand new team at the helm of the entry.
A new Chevrolet LS3 Engine will produce 570bhp and has been repositioned to improve weight distribution, whilst a revised front splitter produces more frontal downforce. To enhance driver experience, internally there is an improved driver interface with Motec dash display, tactile keypad control. Revised brake master cylinders also require less physical effort from the driver under braking.
Rainin SmartStand: The World’s First Intelligent Pipette Stand
METTLER TOLEDO announces the launch of the Rainin SmartStand, an intelligent, highly scalable pipette asset management system that helps busy labs and lab managers proactively manage compliance and save time on recordkeeping and reporting.
METTLER TOLEDO’S new ECB (Easy Control Box) connects to lab sensors and pumps to make real-time measurements and controlled dosing data available to non-experts. Researchers can now quickly evaluate and compare experimental results and make decisions.
February 7, 2017 — METTLER TOLEDO is pleased to announce that the ECB (Easy Control Box) is now available. The ECB connects any lab sensor and pump to make real-time measurement and controlled dosing available to non-experts.
Mount Panorama, Bathurst Australia
5 February, 2017
After 12 hours competing on one of the most demanding circuits in world motorsport, the RA Motorsports supported Ginetta GT4 team came home fourth overall following a sensational debut for the Yorkshire marque in the historic event.
Ginetta Cars made their official debut at Mount Panorama today with the impressive G55 GT4, closing the ledger on the opening day having made a very vocal statement about why they’re at one of the toughest circuits in the world, and just what the competition can expect in Sunday’s once-around-the-clock enduro.
SEATTLE, Jan. 31, 2017 /PRNewswire/ — ReachBio Research Labs (trade name under Reachbio LLC®) has announced the launch of their new drug development platform, cellPrism®. The platform is designed to offer biotechnology and pharmaceutical companies a spectrum of customized in vitro assays to assess and evaluate potential program challenges that may arise during the drug development process.
– Second podium in 4 races following a win in Round 2
– A positive way to end the 2016/17 Asian Le Mans Series
– Further 2017 plans to be announced soon